Department of Rheumatology, Coimbra University Hospital, Coimbra, Portugal.
J Rheumatol. 2011 Jul;38(7):1502-6. doi: 10.3899/jrheum.110279.
The Ankylosing Spondylitis Disease Activity Score (ASDAS) is a new composite index to assess disease activity in ankylosing spondylitis (AS). Criteria for disease activity states and improvement scores are important for use in clinical practice, observational studies, and clinical trials, and have been proposed by the Assessment of SpondyloArthritis international Society (ASAS). At OMERACT 10, our aim was to obtain endorsement from OMERACT for the ASDAS disease activity states and response criteria proposed by the ASAS membership. This article summarizes the associated discussions, the scientific basis of the validation process, and the results from the voting sessions, and identifies areas for research using the ASDAS. OMERACT participants agreed with the selection of cutoff values, which now have the combined endorsement of ASAS and OMERACT and are ready to be used in clinical practice and in research settings.
强直性脊柱炎疾病活动度评分(ASDAS)是一种新的综合指数,用于评估强直性脊柱炎(AS)的疾病活动度。疾病活动状态和改善评分的标准对于临床实践、观察性研究和临床试验非常重要,已经由评估脊柱关节炎国际学会(ASAS)提出。在 OMERACT10 会议上,我们的目标是获得 OMERACT 对 ASAS 成员提出的 ASDAS 疾病活动状态和反应标准的认可。本文总结了相关讨论、验证过程的科学依据以及投票会议的结果,并确定了使用 ASDAS 的研究领域。OMERACT 参与者同意选择临界值,现在这些临界值得到了 ASAS 和 OMERACT 的联合认可,已经准备好用于临床实践和研究环境。